Thanks Don. I’d like to start by running through our reported financial results for the third quarter and the first nine months of 2018 at a summary level. Third quarter total revenue declined to $23.9 million from $27.2 million in 2017. Third quarter net loss was $6.5 million or $0.27 per share versus a net loss of $3.1 million or $0.13 per share last year. Third quarter adjusted EBITDA was negative $2.7 million, compared to positive $1.1 million, a year ago. We define adjusted EBITDA as net income or loss for interest taxes, depreciation, amortization, stock-based compensation expense and other items that we do not believe are indicative of our core operating performance. We encourage 283,000 of patent enforcement costs, during the third quarter of 2018 versus $53,000 in the third quarter of last year. The first nine months, total revenue declined to $68.7 million from $75.3 million last year. Net loss was $20.3 million or $0.86 per share in the first nine months of 2018 versus a net loss of $17.6 million or $0.76 per share last year. And adjusted EBITDA for the first nine months of 2018 was negative $8.3 million, compared to negative $5.5 million last year. We incurred $519,000 of patent enforcement costs in the first nine months of 2018 versus $2.9 million last year. I will now provide additional detail on the components of our third quarter results. First, I'll discuss revenue. Third quarter total revenue was comprised of product revenue of $23.3 million and Research Services revenue of $595,000. During the third quarter, products revenue decreased by $3.5 million versus last year's $26.8 million. This decrease was driven by a decline in project work in the subsea and South American markets during the third quarter of 2018. This decline in project related revenue was partially offset by continued growth in our core petrochemical and refinery markets, most notably in North America and in the U.S. During the quarter, shipments decreased to 7.8 million square feet of aerogel blankets from 8.6 million square feet last year. While our average selling price decreased by 3% to $2.99 per square foot in line with our prior outlook. This decrease in average selling price reflected a year-over-year decrease in the mix of high price of sea products, offset in part by the impact of price increases that we enacted in early 2018. At the time of our second quarter earnings call in August, we anticipated sequential growth in product revenue during both the third and fourth quarters of 2018. This expectation largely reflected increasing levels of project work over the second half of the year. We achieved sequential growth in the third quarter but product revenue increasing by 11% to $23.3 million from $21.1 million in the second quarter. We expect the sequential momentum will continue into the fourth quarter. The product revenue projected in the range of $32.5 million to $37.9 million. Fourth quarter outlook reflects solid projected growth versus third quarter levels in both our base refinery and petrochemical markets and in subsea project work. For the full year, we’re projecting product revenue will range between $100 million and $105 million. This expectation is included in our 2018 guidance. I'll now turn to our Research Services revenue. Our Research Services revenue is related to contract research performed principally for government agencies. Research Services revenue increased during the quarter to $595,000 to $386,000 during the third quarter of 2017. This increase was due to the relative value and timing of research contracts versus last year. For the full year, we expect Research Services revenue of approximately $2 million. This expectation is also included in our 2018 guidance. Next I'll discuss gross profit. Gross profit was $1.5 million or 6% of revenue during the third quarter of 2018, versus $4.9 million or 18% last year. Year-over-year decrease in third quarter gross profit was driven by a decline in production volume. We instituted to manage inventory growth, the increased cost of raw materials led by increases in the cost of silanes. The decline in product revenue and an unfavorable mix of products sold. However, looking forward to the fourth quarter of 2018, we anticipate a significant improvement in gross margin to the low 20s, the expected increases in revenue, output and capacity utilization in the period. We also expect gross margins for the full year to reach the low to mid-teens. Next, I’ll discuss our operating expenses. The third quarter of 2018, operating expenses were essentially flat to last year at approximately $7.9 million. Increased sales and marketing expenses of $300,000 in the third quarter were fully offset by decreases in research and development, in general and administrative costs. We are reducing our 2018 full year operating expense projections between $35.8 million, at the low end of our revenue guidance range and $37.1 million at the high end of our revenue guidance range. Next I'll discuss our balance sheet and cash flow for the first nine months of 2018. Cash used in operations of $8.7 million, during the first nine months reflected our adjusted EBITDA of negative $8.3 million and an investment in working capital of $400,000, principally due to a decrease in accounts payable and accrued expenses during the period. Capital expenditures during the first nine months included investments in our EP20 initiatives and totaled $2.6 million, down from $5.4 million in capital spending last year. During the nine months, we also received prepayments from BASF, the aggregate of $5 million. At the end of the third quarter, we had $5.2 million of cash, net current assets of $18.6 million, $5.2 million borrowed under our revolving credit facility, shareholders equity of $83.5 million. In addition, we had access to an additional $8 million available under our revolving credit facility at the end of the period. We're revising our full year financial outlook for 2018, total revenues expected to range between $102 million and $107 million, revised from prior guidance of $102 million to $112 million. Net loss is expected to range between $21.6 million to $22.6 million, revised from prior guidance of $20.6 million to $22.6 million. Adjusted EBITDA is expected to range between a loss of $6 million and a loss of $7 million, revised from prior guidance of a loss of $5 million to $7 million. EPS is expected to range between the loss of $0.91 and a loss of $0.95 per share revised from prior guidance of a loss of $0.87 to $0.95 per share. EPS guidance assumes a weighted average of 23.7 million shares outstanding for the year. 2018 outlook also assumes depreciation and amortization of $10.8 million, stock-based compensation of $4.3 million and interest expense at $500,000. In addition, this financial outlook includes $900,000 of cost and expenses associated with our patent enforcement actions for the year. And we expect a gross margin in the low to mid-teens and average selling price of $2.98 per square foot, plus or minus a $0.02 for the full year. Turning to cash at an aggregate level within the context of the adjusted range, set out in our 2018 full year outlook. We expect to exit 2018 with between $6.8 million and $8.3 million of cash on hand and outstanding balance of $5.2 million on our revolving credit facility. We also projected capital expenditures including funds for our EP20 initiative and totaled approximately $3.8 million for the year. Although, we don't normally provide quarterly guidance, I'd like to emphasize that our updated full year 2018 outlook includes our expectations for continued strengthening during the fourth quarter. The differential between our 2018 full year guidance and our nine months actuals indicates that fourth quarter total revenue is expected to range between $32.9 million and $38.3 million. Fourth quarter net loss is expected to range between $1.3 million and $2.3 million. Fourth quarter adjusted is expected to range between a positive $1.23 million and $2.3 million. And fourth quarter EPS is expected to range between a loss of $0.05 and $0.10 per share. As discussed earlier, we expect our gross margin to exceed 20% during the fourth quarter. As Don mentioned, looking forward to 2019. We are projecting to grow total revenue in excess of 20% to reduce our net loss and to deliver positive adjusted EBITDA. This projected improvement in financial performance reflects our expectation of continued volume growth in our core petrochemical and refinery markets. The strengthening pipeline of 2019 project opportunities, particularly in the subsea and LNG markets and a 2019 price increase designed to offset recent increases in raw material costs and to maintain the economics of our business. We currently plan to issue detailed 2019 guidance at the time of our fourth quarter conference call in February 2019. Now I’ll turn the call back to Jesse for Q&A. Thank you.